Evaluation of medical costs avoided when new oral anticoagulants are used for extended treatment of venous thromboembolism based on clinical trial results
Crossref DOI link: https://doi.org/10.1007/s11239-014-1158-2
Published Online: 2014-12-11
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Amin, Alpesh
Jing, Yonghua
Trocio, Jeffrey
Lin, Jay
Lingohr-Smith, Melissa
Graham, John
Text and Data Mining valid from 2014-12-11